Ipilimumab/pembrolizumabGraves' ophthalmopathy and diarrhoea: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1737卷 / 1期

关键词：

D O I：

10.1007/s40278-019-57268-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：173 / 173

相关论文

共 50 条

[1] Ipilimumab/nivolumabColitis and diarrhoea: case report
[J]. Reactions Weekly, 2019, 1741 (1) : 142 - 142
[2] Ipilimumab/nivolumabMucositis and diarrhoea: case report
[J]. Reactions Weekly, 2019, 1771 (1) : 178 - 178
[3] Ipilimumab/nivolumabDermatitis, diarrhoea and hepatitis: case report
[J]. Reactions Weekly, 2019, 1753 (1) : 202 - 202
[4] Ipilimumab/nivolumabThrombotic microangiopathy and diarrhoea: case report
[J]. Reactions Weekly, 2021, 1869 (1) : 196 - 196
[5] Ipilimumab/nivolumabColitis, diarrhoea and skin rash: case report
[J]. Reactions Weekly, 2019, 1739 (1) : 158 - 158
[6] Binimetinib/encorafenib/ipilimumab/nivolumabColitis and diarrhoea: case report
[J]. Reactions Weekly, 2023, 1959 (1) : 147 - 147
[7] Ipilimumab/pembrolizumabGuillain-Barre-syndrome and diarrhoea: case report
[J]. Reactions Weekly, 2020, 1812 (1) : 167 - 167
[8] Infliximab/ipilimumab/methylprednisoloneAcneiform skin rash, diarrhoea and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1907 (1) : 257 - 257
[9] Ipilimumab/NivolumabImmune checkpoint inhibitor-related diarrhoea and colitis: case report
[J]. Reactions Weekly, 2020, 1818 (1) : 153 - 153
[10] Ipilimumab/nivolumabColitis and diarrhoea: 11 case reports
[J]. Reactions Weekly, 2020, 1810 (1) : 120 - 120

← 1 2 3 4 5 →